PINK1-AS: A Promising Drug Target / Biomarker (G100861548)

Target Name: PINK1-AS

NCBI ID: G100861548

PINK1-AS

Other Name(s): NAPINK1 | PINK1AS | PINK1-AS1 | PINK1 antisense RNA

PINK1-AS: A Promising Drug Target / Biomarker

Pink1-AS is a protein that is expressed in the brain and is involved in the regulation of cell growth, differentiation, and survival. It has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In this article, we will discuss the biology and potential therapeutic applications of Pink1-AS.

Structure and Function

Pink1-AS is a transmembrane protein that is expressed in the brain and other tissues. It consists of an extracellular domain, a transmembrane domain, and an intracellular domain. The extracellular domain is involved in the protein's ability to interact with other proteins, while the transmembrane domain is responsible for the protein's structure and function. The intracellular domain is involved in the protein's ability to interact with intracellular signaling pathways.

Pink1-AS is involved in the regulation of cell growth, differentiation, and survival. It plays a role in the development and maintenance of neuronal stem cells, and is also involved in the regulation of neurotransmitter release and synaptic plasticity. Pink1-AS has been shown to be involved in the development and progression of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and neuroblastoma.

Potential Therapeutic Applications

Pink1-AS has the potential to be a drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, Pink1-AS has been shown to be involved in the development and progression of neuroblastoma, a type of cancer that affects the cells that give rise to neurotransmitters.

In addition to its potential role in cancer, Pink1-AS is also potential target for neurodegenerative diseases. The neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, are characterized by the progressive loss of brain cells and the development of neurotransmitter deficits. Pink1-AS has been shown to be involved in the regulation of neurotransmitter release and synaptic plasticity, which are key factors in the development and progression of these diseases.

Pink1-AS may also be a potential target for autoimmune disorders. Autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis, are characterized by the immune system attacking the body's own tissues. Pink1-AS has been shown to be involved in the regulation of immune cell function, which may be involved in the development and progression of autoimmune disorders.

Conclusion

Pink1-AS is a protein that is involved in the regulation of cell growth, differentiation, and survival. It has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of Pink1-AS in these diseases and to develop effective therapies.

Protein Name: PINK1 Antisense RNA

The "PINK1-AS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PINK1-AS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets